PD-L1 expression and CD274 gene alteration in triple-negative breast cancer: implication for prognostic biomarker

PURPOSE: To estimate the therapeutic potential of PD-L1 inhibition in breast cancer, we evaluated the prevalence and significance of PD-L1 protein expression with a validated antibody and CD274 gene alternation in a large cohort of triple negative breast cancer (TNBC) and correlated with clinicopath...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lei, Li, Wenbin, Zhu, Xinxin, Ling, Yun, Qiu, Tian, Dong, Lin, Fang, Yi, Yang, Hongying, Ying, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916110/
https://www.ncbi.nlm.nih.gov/pubmed/27390646
http://dx.doi.org/10.1186/s40064-016-2513-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916110/
https://www.ncbi.nlm.nih.gov/pubmed/27390646
http://dx.doi.org/10.1186/s40064-016-2513-x

Ejemplares similares